Israel's Redhill Biopharma signs manufacturing deal for potential Covid-19 treatment 14.10.20 | Reuters
Gastro Treatment Company RedHill Jumps on Nasdaq Following Successful Clinical Trial 30.07.18 | Lilach Baumer